GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Metropolis Healthcare Ltd (BOM:542650) » Definitions » ROE % Adjusted to Book Value

Metropolis Healthcare (BOM:542650) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Metropolis Healthcare ROE % Adjusted to Book Value?

Metropolis Healthcare's ROE % for the quarter that ended in Dec. 2024 was 10.60%. Metropolis Healthcare's PB Ratio for the quarter that ended in Dec. 2024 was N/A. Metropolis Healthcare's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.


Metropolis Healthcare ROE % Adjusted to Book Value Historical Data

The historical data trend for Metropolis Healthcare's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metropolis Healthcare ROE % Adjusted to Book Value Chart

Metropolis Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only 2.17 1.84 2.29 2.36 1.52

Metropolis Healthcare Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.65 - 1.66 -

Competitive Comparison of Metropolis Healthcare's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Metropolis Healthcare's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Metropolis Healthcare's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Metropolis Healthcare's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Metropolis Healthcare's ROE % Adjusted to Book Value falls into.


;
;

Metropolis Healthcare ROE % Adjusted to Book Value Calculation

Metropolis Healthcare's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=12.26% / 8.07
=1.52%

Metropolis Healthcare's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=10.60% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Metropolis Healthcare ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Metropolis Healthcare's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Metropolis Healthcare Business Description

Traded in Other Exchanges
Address
Dr. Annie Besant Road, 4th Floor, East Wing, Plot-254 B, Nirlon House, Worli, Mumbai, MH, IND, 400 030
Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.

Metropolis Healthcare Headlines

No Headlines